1998
DOI: 10.1016/s0022-5223(98)70376-9
|View full text |Cite
|
Sign up to set email alerts
|

l-Arginine, a nitric oxide precursor, attenuates ischemia-reperfusion injury by inhibiting inositol-1,4,5-triphosphate

Abstract: These data suggest that L-arginine pretreatment may reduce calcium overload by increasing cyclic guanosine monophosphate production, which in turn downregulates inositol triphosphate synthesis during reperfusion.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
12
0

Year Published

2000
2000
2013
2013

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(12 citation statements)
references
References 26 publications
0
12
0
Order By: Relevance
“…inflammatory response by compensating the reduced NO production from ecNOS. 35 The efficacy of NO supplementation has been demonstrated, 36,37 and we have demonstrated that selective iNOS inhibition aggregates CPB-induced inflammation. 28 Therefore, enhanced NO production is considered an adaptive response and a key process for attenuating the development of this response.…”
Section: Discussionmentioning
confidence: 82%
“…inflammatory response by compensating the reduced NO production from ecNOS. 35 The efficacy of NO supplementation has been demonstrated, 36,37 and we have demonstrated that selective iNOS inhibition aggregates CPB-induced inflammation. 28 Therefore, enhanced NO production is considered an adaptive response and a key process for attenuating the development of this response.…”
Section: Discussionmentioning
confidence: 82%
“…The mechanisms of NO in modulating cardiac function during I/R injury proposed in those studies are quite numerous. NO has been reported to exert multiple beneficial effects: inhibiting inositol-1,4,5-triphosphate and reducing calcium overload, 14 mediating protein kinase C translocation, 19 and inhibiting neutrophil-associated injury. 20 On the contrary, NO also has been reported to react with superoxide to form peroxynitrite, which is considered cytotoxic.…”
Section: Discussionmentioning
confidence: 99%
“…Under our experimental conditions, it was not possible to determine differences in cardiac function between D-or Larginine-treated hearts, despite a slight increase in postischemic peak LEDVP and a decrease in heart rate. Many authors have described beneficial effects of L-arginine treatment on the recovery of myocardial function during reperfusion (Engelman et al, 1996;Brunner et al, 1997;Wang et al, 1997;Mizuno et al, 1998;Padilla et al, 2000), whereas others have shown a harmful effect of L-arginine administration (Takeuchi et al, 1995;Mori et al, 1998). These discrepancies can be attributed to different experimental models but also to the critical timing of this amino acid administration.…”
Section: Tablementioning
confidence: 99%
“…These discrepancies can be attributed to different experimental models but also to the critical timing of this amino acid administration. In fact, L-arginine seems even more powerful as a pretreatment (Engelman et al, 1996;Wang et al, 1997;Mizuno et al, 1998), and sometimes deleterious during reperfusion (Takeuchi et al, 1995;Engelman et al, 1996). Therefore, the absence of functional parameters' variations between D-or L-arginine observed under our experimental conditions might be the addition of both beneficial and detrimental effects of L-arginine administration.…”
Section: Tablementioning
confidence: 99%
See 1 more Smart Citation